Skip to content

Clinical trials

Suspended Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Status: Suspended Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20131
20171
20182
20212
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Suspended11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fox Chase Cancer Center2
Dana-Farber Cancer Institute1
Favrille1
Insel Gruppe AG, University Hospital Bern1
Jiangsu HengRui Medicine Co., Ltd.1
Leland Metheny1
MedImmune LLC1
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd1
SymBio Pharmaceuticals1
The Christie NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma11
Dendritic Cell Sarcoma, Interdigitating2
Lymphoma, Large B-Cell, Diffuse2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Burkitt Lymphoma1
Dendritic Cell Sarcoma, Follicular1
Epstein-Barr Virus Infections1
Hematologic Neoplasms1
Histiocytic Sarcoma1
Hodgkin Disease1

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.